Detalhe da pesquisa
1.
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment.
Cancer Immunol Immunother
; 72(11): 3739-3753, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707586
2.
Prognostic impact of peripheral eosinophil counts in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy.
Cytotherapy
; 25(6): 573-577, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456447
3.
Risk of HBV reactivation in relapsed or refractory diffuse large B-cell lymphoma patients receiving Bruton tyrosine kinase inhibitors therapy.
Front Immunol
; 13: 982346, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119029
4.
Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis.
Front Immunol
; 12: 638678, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34335561
5.
Different sites of extranodal involvement may affect the survival of patients with relapsed or refractory non-Hodgkin lymphoma after chimeric antigen receptor T cell therapy.
Front Med
; 14(6): 786-791, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32789732
6.
Chimeric antigen receptor T-cell therapy: a promising treatment modality for relapsed/refractory mantle cell lymphoma.
Front Med
; 14(6): 811-815, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651937
7.
Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma.
Blood Adv
; 6(1): 293-296, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758063
8.
SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.
Oncotarget
; 7(12): 13538-50, 2016 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26646449
9.
Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia.
Mol Clin Oncol
; 3(3): 730-736, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26161258
10.
SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair.
Oncol Rep
; 34(6): 2935-42, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26398583